Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Potassium chloride acts as a source of potassium ions, essential for maintenance of cellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function. Dextrose provides caloric support and is metabolized to carbon dioxide and water, yielding energy. Sodium chloride maintains osmotic balance and fluid distribution.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion. Dose depends on electrolyte requirements, typically for maintenance or replacement. Potassium: 10-20 mEq/hour, not exceeding 20 mEq/hour or 200 mEq/day. Dextrose 10%: 100-200 mL/hour, not to exceed glucose infusion rate of 5 mg/kg/min. Sodium chloride 0.45%: as needed based on sodium deficit and fluid balance. Administer via central or peripheral line.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Potassium: Not applicable as the drug contains potassium, which distributes and is regulated; no terminal elimination half-life. Dextrose: variable, but glucose half-life ~2-4 hours depending on insulin. Sodium and chloride: long half-life, regulated by kidneys. Clinical context: drug used for repletion, not a typical pharmacokinetic agent.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Potassium: primarily renal (>90%) as K+; chloride: renal, following Na+ and Cl- reabsorption. Dextrose: metabolized. Sodium and chloride: renal handling matches intake. No biliary/fecal elimination for these ions.
Category C
Category A/B
Electrolyte
Electrolyte